Linking Intermacs to the World:

Slides:



Advertisements
Similar presentations
Heart Failure and Transplant Medicine Council Immediate Past Chair: David A. Baran, MD Chair: Lee R. Goldberg, MD, MPH Vice-Chair Elect Brad Dyke MD.
Advertisements

VALUE BASED CARE: The Role of INTERMACS INTERMACS 8 TH Annual Meeting James B, Young, M.D. Study Chair – INTERMACS May 5 th, 2014.
Sixth Annual Meeting March 12, :00am to 4:00pm Crowne Plaza National Airport Arlington, VA INTERMACS Annual Meeting March 2012.
Donor Utilization: Making Use of a Precious Resource in Cardiac Transplant Jason W. Smith, MD Assistant Professor of Surgery The University of Washington.
Equipoise Does Not Exist for REVIVE IT Andrew Boyle, MD Heart and Vascular Center Director, Florida Chairman of Cardiology Medical Director of Heart Failure,
Predicting Major Outcomes after MCSD Implant 1 Risk Factors for Death, Transplant, and Recovery James Kirklin, MD David Naftel, PhD.
Coordinator Training Session: March 11, 2012 Major Changes in Data EntryMyers 1 What is the same? What is reduced/removed? What is added/expanded? INTERMACS.
Keith Aaronson, Mark Slaughter, Edwin McGee, William Cotts, Michael Acker, Mariell Jessup, Igor Gregoric, Pranav Loyalka, Valluvan Jeevanandam, Allen Anderson,
Sixth Annual Meeting Coordinator Training Session March 11, :00pm to 9:00pm Arlington, VA 1 INTERMACS Coordinator Training March 2012.
Contemporary Outcomes With the HeartMate II® LVAS
Predicting Major Outcomes after MCSD Implant 1 Risk Factors for Death, Transplant, and Recovery James Kirklin, MD David Naftel, PhD.
Interagency Registry for Mechanically Assisted Circulatory Support Marissa A. Miller, DVM, MPH National Heart, Lung, & Blood Institute.
Josef Stehlik, MD, MPH Associate Professor of Medicine Medical Director, Heart Transplant Program University of Utah School of Medicine Director, ISHLT.
HeartWare HVAD: Risk Factors for Adverse Outcomes Mark S. Slaughter, MD Professor and Chair Department Cardiovascular and Thoracic Surgery University of.
MCS in Special Populations: The Use of Mechanical Support in Adults with Congenital Heart Disease 9 th Annual Meeting May 15, 2015 Christina VanderPluym,MD.
Registry Data Collection in Pediatric VADs: Challenges and Opportunities INTERMACS Eighth Annual Meeting May 5, 2014 David Rosenthal, MD Stanford Children’s.
7.35PHTS Business DCC Update/QID. Naftel Database CommitteeR. Gajarski (W. Mahle) Foundation UpdateA. Dipchand Financial RoadmapW. Mahle 8:15 Hard to Forget:
INTERMACS: June 2006 – December 2012: CMS Report Adults: n=7849 All primary implants as of 12/31/2012 n= 7928 Pediatric patients: n=79 (patients < 19 yrs.
Risk Factors for Adverse Outcome after HeartMate II Jennifer Cowger, MD, MS St. Vincent Heart Center of Indiana Advanced Heart Failure, Transplant, & Mechanical.
Pediatric Mechanical Circulatory Support (MCS) Ivan Wilmot, MD Heart Failure, Transplant, MCS Assistant Professor The Heart Institute Cincinnati Children’s.
Industry Prospective Robin Bostic, Thoratec VP Health Policy and Health Economics INTERMACS Industry Sub-Committee Representative Our Future.
“Rise of the Machines” Todd D. Edwards MD FACC FACP FASNC.
MCSRN Mechanical Circulatory Support Research Network
Mechanical Circulatory Support in Special Populations Renzo Y. Loyaga-Rendon MD.,PhD.. Assistant Professor Advanced Heart Failure Section University of.
Analysis of Pump Thrombosis in the Intermacs Database Michael Acker William Measey Professor of Surgery Chief of Division of Cardiovascular Surgery Director.
Session III: Linking Intermacs to the World: The Power of Collaboration Intermacs and the ISHLT Registry for Mechanically Assisted Circulatory Support.
1 Data Quality Report Quality Assurance Report Live Data Download Site Datasets (SAS) Research Datasets Customized Cohort Reports Outcome Analytics Patient.
1 Intermacs 10 th Annual Meeting and Scientific Sessions Intermacs: Products for the Sites Friday, March 11, 2016: 7:00-8:30pm Omni Hotel, Grand Ballroom.
Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Results of the Destination Therapy Post-Food and.
Annual Spring Meeting April 5, 2017
10th Annual Meeting: Friday, March 11th – Products for the Sites
Annual Fall Meeting November 13, 2016
Total Artificial Heart (TAH): Survival Outcomes, Risk Factors,
James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L
Annual Fall Meeting November 13, 2016
Jennifer A. Cowger, MD, Matthew A
Intermacs and the Scientific Registry of Transplant Recipients (SRTR)
Insights from the NCDR® STS/ACC TVT Registry.
Αντιμετώπιση καρδιακής ανεπάρκειας προχωρημένου και τελικού σταδίου
Adverse Events in Children Implanted With Ventricular Assist Devices in the US: Data From the Pediatric Interagency Registry for Mechanical Circulatory.
Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients  James K. Kirklin, MD, David C. Naftel,
Pedimacs 2016.
ELSO Registry Data Summary
HEART-LUNG TRANSPLANTATION
in the MCSD Evolution/Revolution Crowne Plaza National Airport
Quarterly Statistical Report st Quarter
Annual Spring Meeting April 26, 2016
Annual Spring Meeting April 26, 2016
HEART-LUNG TRANSPLANTATION
HEART-LUNG TRANSPLANTATION
Durable Mechanical Circulatory Support in Advanced Heart Failure
Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation?  James K. Kirklin, MD, David C. Naftel,
ISHLT iPHF REGISTRY Status and Update
HEART-LUNG TRANSPLANTATION
Agenda 8:00pm Welcome Marc Richmond / Elfi Pahl 8:10pm
Impact of Marital Status on LVAD Mortality: A Single Center Experience Linda Njoroge MD, Mohamed Khayata MD, Kevin Charnas, Paul Bate, Madison Edge, James.
Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry  Jens Garbade, MD, PhD, Finn Gustafsson,
Quarterly Statistical Report th Quarter
Adverse events in contemporary continuous-flow left ventricular assist devices: A multi- institutional comparison shows significant differences  John M.
Interagency Registry for Mechanically Assisted Circulatory Support
Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011  William L.
William L. Holman, MD, James K. Kirklin, MD, David C
HEART-LUNG TRANSPLANTATION
Jacqueline Baras Shreibati et al. JCHF 2017;j.jchf
Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure  Erin M. Schumer,
Durable Ventricular Assist Device Support for Failing Systemic Morphologic Right Ventricle: Early Results  Ed Peng, FRCS(CTh), John J. O’Sullivan, FRCP(UK),
Quarterly Statistical Report rd Quarter
HEART-LUNG TRANSPLANTATION
Presentation transcript:

Linking Intermacs to the World: Intermacs 10th Annual Meeting and Scientific Sessions Session III Linking Intermacs to the World: The Power of Collaboration   David C. Naftel, PhD Intermacs Director of Research P = presentation, M=manuscript,

Intermacs 10th Annual Meeting and Scientific Sessions NHLBI FDA Pre-Market CMS FDA Post-Market Clinicians Hospitals Industry

The Interagency Registry for Mechanically Assisted Circulatory Support Intermacs 10th Annual Meeting and Scientific Sessions The Interagency Registry Collaboration for Mechanically Assisted Circulatory Support P = presentation, M=manuscript,

Collaboration The Interagency Registry Intermacs 10th Annual Meeting and Scientific Sessions The Interagency Registry for Mechanically Assisted Circulatory Support Collaboration P = presentation, M=manuscript,

Intermacs 10th Annual Meeting and Scientific Sessions PHTS SRTR 5

Summary Hospitals and Patients Registry Data Collection Began Family of MACS Research Collaborations: 2006 – March, 2016 Summary Hospitals and Patients Registry Data Collection Began Hospitals Patients Intermacs June 2006 157 17,075 Medamacs May 2013 11 171 Pedimacs Sept 2012 66 302 P = presentation, M=manuscript,

Summary of Publications and Abstracts Registry Abstracts Publications Family of MACS Research Collaborations: 2006 – March, 2016 Summary of Publications and Abstracts Registry Abstracts Publications Intermacs 78 44 Medamacs 2 1 Pedimacs 3 Overall 83 47 Last Year 27 11 P = presentation, M=manuscript,

Family of MACS Research Collaborations: 2006 – March, 2016 Intermacs Pedimacs Medamacs Imacs Began Data Collection June 2006 Sept 2012 May 2013 Jan 2013 Total hospitals 157 66 11 20 (Individual) 278 (Total) Total patients 17,075 302 171 8497 Research proposals 253 8 5 2 Accepted proposals 1 Datasets to researchers 54 In progress studies: DCC 22 6 4 Publications 44 3 Unique authors 148 18 13 12 P = presentation, M=manuscript,

Intermacs 10th Annual Meeting and Scientific Sessions 8:20 AM Session III: Linking Intermacs to the World: The Power of Collaboration - D. Naftel Moderator Overview D. Naftel 8:30 AM Intermacs and the Scientific Registry of Transplant Recipients J. Tallaj 8:40 AM Pedimacs and the Pediatric Heart Transplant Study 8:50 AM Intermacs and the Centers for Medicare and Medicaid F. Pagani 9:05 AM Intermacs and the ISHLT Registry for Mechanically Assisted Circulatory Support (IMACS) R. Xie 9:20 AM Intermacs and Revival K. Aaronson 9

Past and Current Collaborations Intermacs 10th Annual Meeting and Scientific Sessions Past and Current Collaborations NIH + Investigators Sustaining Quality of Life of the Aged (Sustain-It) Mechanical Circulatory Support: Measures of Adjustment and Quality of Life CORA: Cardiac Outcomes Risk Assessment Pump Thrombosis Study (with FDA, Industry) Revive-It Revival   10

Past and Current Collaborations Intermacs 10th Annual Meeting and Scientific Sessions Past and Current Collaborations CMS + Investigators CMS Payments and Utilization of Durable Mechanical Circulatory Assist Devices for Advanced Heart Failure in Intermacs MEDCAC Analysis Pedimacs + Investigators Collaboration with PHTS   11

Past and Current Collaborations Intermacs 10th Annual Meeting and Scientific Sessions Past and Current Collaborations Industry Thoratec: HMII BTT Post Approval Study Thoratec: HMII DT Post Approval Study HeartWare: HVAD Pre-Market Study HeartWare: HVAD Post-Market Study HeartWare: Thoracotomy Study SynCardia: Console Analysis Berlin Heart: Humanitarian Use (consultant)   12